Publications

Papers

2015

  1. Iagaru A, Mosci C, Mittra E, Zaharchuk G, Fischbein N, Harsh G, Li G, Nagpal S, Recht L, Gambhir SS. Glioblastoma Multiforme Recurrence: An Exploratory Study of 18F FPPRGD2 PET/CT. Radiological Society of North America (Manuscript accepted for publication). 
  2. Andre JB, Nagpal S, Hippe DS, Ravanpay AC, Schmiedeskamp H, Bammer R, Palagallo GJ, Recht L, Zaharchuk G. Cerebral Blood Flow Changes in Glioblastoma Patients Undergoing Bevacizumab Treatment Are Seen in Both Tumor and Normal Brain. The Neuroradiology Journal (Manuscript accepted for publication). 
  3. Amukotuwa SA, Yu C, Zaharchuk G. 3D Pseudocontinuous arterial spin labeling in routine clinical practice: A review of clinically significant artifacts.Jounral of Magnetic Resonance Imaging.
  4. Wheeler HM, Mlynash M, Inoue M, Tipirnini A, Liggins J, Bammer R, Lansberg MG, Kemp S, Zaharchuk G, Straka M, Albers.The growth rate of early DWI lesions is highly variable and associated with penumbral salvage and clinical outcomes following endovascular reperfusion. World Stroke Organization
  5. Iagaru A, Mittra E, Minamimoto R, Jamali M, Levin C, Quon A, Gold G, Herfkens R, Vasanawala S, Gambhir SS, Zaharchuk G. Simultaneous whole-body time-of-flight 18F-FDG PET/MRI: a pilot study comparing SUVmax with PET/CT and assessment of MR image quality.Clinical Nuclear Medicine (Manuscript accepted for publication). 
  6. Vora N, Tung CE, Mlynash M, Garcia M, Kemp S, Kleinman J, Zaharchuk G, Albers G, Olivot JM. TIA triage in emergency department using acute MRI (TIA-TEAM): a feasibility and safety study. Journal of Stroke (Manuscript accepted for publication). 
  7. Kristen W. Yeom, Matus Straka, Michael Iv, Michael E. Moseley, Patrick D. Barnes, Stefan Skare, Samantha J. Holdsworth.Intensity-Corrected Dual-Echo Echo-Planar Imaging (DE-EPI) for Improved Pediatric Brain Diffusion ImagingPloS One Journals.
  8. Michael Iv, Nicholas Telischak, Dan Feng, Samantha J Holdsworth, Kristen W Yeom, Heike E Daldrup. Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumorsFurture Medicine. Journal of Magnetic Resonance Imaging (Manuscript accepted for publication). 

 

2014

  1. Holdsworth S.J., Yeom K., Moseley M., Skare S. Fast 3D motion corrected susceptibility-weighted imaging using short-axis propeller (SAP)-EPIJournal of Magnetic Resonance Imaging (Manuscript accepted for publication).
  2. Holdsworth S.J., Skare S., Yeom K., Antonucci M.U., Andre J.B., Rosenberg J., Straka M., Aksoy M., Fischbein N.J., Bammer R., Moseley M., Zaharchuk G. Diffusion-weighted Imaging (DWI) with Dual Echo EPI for Improved Lesion SensitivityAmerican Journal of Neuroradiology, In press.
  3. Ni W., Christen T., Zun Z. and Zaharchuk G. Comparison of R2′ measurement methods in the normal brain at 3 tesla. Magnetic Resonance in Medicine. 2014. doi: 10.1002/mrm.25232
  4. Christen T, Jahanian H, Ni WW, Qiu D, Moseley ME, Zaharchuk G. Non-Contrast Mapping of Arterial Delay and Functional Connectivity Using Resting-State Functional MRI: A Study in Moyamoya Patients. Journal of Magnetic Resonance Imaging. 2014. doi: 10.1002/jmri.24558.
  5. Christen T., Bouzat P., Pannetier N., Coquery N., Moisan A., Lemasson B., Thomas S., Grillon E., Detante O., Remy C., Payen JF., Barbier E. Tissular Oxygenation Mapping with Magnetic Resonance Imaging. Journal of Cerebral Blood Flow and Metabolism. 2014. doi: 10.1038/jcbfm.2014.116.
  6. Zun Z., Hargreaves B.A., Rosenberg J., Zaharchuk G. Improved multislice perfusion imaging with velocity-selective arterial spin labeling. Journal of Magnetic Resonance Imaging. 2014. doi: 10.1002/jmri.24652
  7. Zun Z., Shankaranarayanan A., Zaharchuk G. Pseudocontinuous arterial spin labeling with prospective motion correction (PCASL-PROMO). Magnetic Resonance in Medicine. 2014. doi: 10.1002/mrm.25024
  8. Soman S., Holdsworth S.J., Skare S., Andre J.B., Van A.T., Aksoy M., Bammer R., Rosenberg J., Barnes P.D., Yeom K.W. Effect of Number of Acquisitions in Diffusion Tensor Imaging of the Pediatric Brain: Optimizing Scan Time and Diagnostic Experience.  Journal of Neuroimaging. 2014. doi: 10.1111/jon.12093. 
  9. Christen T., Pannetier N., Ni W.W., Qiu D., Moseley M., Schuff N., Zaharchuk G. MR Vascular Fingerprinting: a New Approach to Compute Blood Volume, Mean Vessel Radius and Blood Oxygenation Maps in the Human BrainNeuroImage. 2014. 89: 262-270.
  10. Jahanian H., Ni W.W., Christen T., Moseley M.E., Tamura M.K., Zaharchuk G. Spontaneous BOLD Fluctuations in Young Healthy Subjects and Elderly Patients with Chronic Kidney Disease.Plos One. 2014. 9 (3)
  11. Zun Z., Hargreaves,B.A., Pauly J., Zaharchuk G. Near-contiguous spin echo imaging using matched-phase RF and its application in velocity-selective arterial spin labeling.Magnetic Resonance in Medicine. 2014; 71 (6): 2043-2050
  12. Olivot J. M., Mlynash M., Inoue M., Marks M.P., Wheeler H.M., Kemp S., Straka M., Zaharchuk G., Bammer R., Lansberg M.G., Albers G.W. Hypoperfusion Intensity Ratio Predicts Infarct Progression and Functional Outcome in the DEFUSE 2 Cohort. STROKE. 2014; 45 (4): 1018-1023.
  13. Inoue M., Mlynash M., Christensen S., Wheeler H.M., Straka M., Tipirneni A., Kemp S.M., Zaharchuk G., Olivot J., Bammer R., Lansberg M.G., Albers G.W. Early diffusion-weighted imaging reversal after endovascular reperfusion is typically transient in patients imaged 3 to 6 hours after onset. STROKE. 2014; 45 (4): 1024-1028.
  14. Marks M.P., Lansberg M.G., Mlynash M., Olivot J., Straka M., Kemp S., McTaggart R., Inoue M., Zaharchuk G., Bammer R., Albers G.W. Effect of collateral blood flow on patients undergoing endovascular therapy for acute ischemic stroke. STROKE. 2014; 45 (4): 1035-1039.

2013

  1. Schmiedeskamp H., Andre J.B., Straka M., Christen T., Nagpal S., Recht L., Thomas R.P., Zaharchuk G., Bammer R. Simultaneous perfusion and permeability measurements using combined spin- and gradient-echo MRIJournal of Cerebral Blood Flow and Metabolism. 2013. 33 (5): 732-743.
  2. Christen T., Ni W.W., Qiu D., Schmiedeskamp H., Bammer R., Moseley M.E., Zaharchuk G. High Resolution Cerebral Blood Volume Imaging in Humans using the blood pool contrast agent ferumoxytol. Magnetic Resonance in Medicine. 2013; 70 (3): 705-710.
  3. Bouchet A., Lemasson B., Christen T., Potez M., Rome C., Coquery N., Le Clec’h C., Moisan A., Brauer-Krisch E., Leduc G., Remy C., Laissue J.A., Barbier E.L., Brun E., Serduc R.Synchrotron microbeam radiation therapy induces hypoxia in intracerebral gliosarcoma but not in the normal brain.Radiotherapy and Oncology. 2013.
  4. Pannetier N., Sohlin M., Christen T., Schad L.R., Schuff N. Numerical modeling of susceptibility-related MR signal dephasing with vessel size measurement: Phantom validation at 3T. Magnetic Resonance in Medicine. 2013.
  5. Christen T., Bolar D., Zaharchuk G. Imaging Brain Oxygenation with MRI Using Blood Oxygenation Approaches: Methods, Validation, and Clinical Applications. American Journal of Neuroradiology. 2013; 34 (6): 1113-1123 .
  6. Wintermark M., Sanelli P.C., Albers G.W., Bello J.A., Derdeyn C.P., Hetts S.W., Johnson M.H., Kidwell C.S., Lev M.H., Liebeskind D.S., Rowley H.A., Schaefer P.W., Sunshine J.L., Zaharchuk G., Meltzer C.C. Imaging Recommendations for Acute Stroke and Transient Ischemic Attack PatientsJournal of the American College of  Radiology. 2013; 10 (11): 828-832.
  7. Wheeler H.M., Mlynash M., Inoue M., Tipirneni A., Liggins J., Zaharchuk G., Straka M., Kemp S., Bammer R., Lansberg M.G., Albers G.W. Early Diffusion-Weighted Imaging and Perfusion-Weighted Imaging Lesion Volumes Forecast Final Infarct Size in DEFUSE 2.STROKE. 2013; 44 (3): 681-685. 
  8. D'Arceuil H., Coimbra A., Triano P., Dougherty M., Mello J., Moseley M., Glover G., Lansberg M., Blankenberg F. Ferumoxytol enhanced resting state fMRI and relative cerebral blood volume mapping in normal human brain. NeuroImage.  2013; 83: 200-209. 
  9. Pannetier N.A., Debacker C.S., Mauconduit F., Christen T., Barbier E.L. A Simulation Tool for Dynamic Contrast Enhanced MRIPlos One.  2013; 8 (3). 

 

2012

  1. Andre J.B., Zaharchuk G., Saritas E., Komakula S., Shankaranarayan A., Banerjee S., Rosenberg J., Nishimura D.G., Fischbein N.J. Clinical Evaluation of Reduced Field-of-View Diffusion-Weighted Imaging of the Cervical and Thoracic Spine and Spinal Cord. American Journal of Neuroradiology.  2012; 33 (10): 1860-1866. 
  2. Lansberg M.G., Straka M., Kemp S., Mlynash M., Wechsler L.R., Jovin T.G., Wilder M.J., Lutsep H.L., Czartoski T.J., Bernstein R.A., Chang C.W., Warach S., Fazekas F., Inoue M., Tipirneni A., Hamilton S.A., Zaharchuk G., Marks M.P., Bammer R., Albers G.W. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study.Lancet Neurology. 2012; 11 (10): 860-867. 
  3. McTaggart R.A., Fischbein N.J., Elkins C.J., Hsiao A., Cutalo M.J., Rosenberg J., Dake M.D., Zaharchuk G. Extracranial Venous Drainage Patterns in Patients with Multiple Sclerosis and Healthy ControlsAmerican Journal of Neuroradiology. 2012; 33 (8): 1615-1620. 
  4. Lemasson B., Christen T., Serduc R., Maisin C., Bouchet A., Le duc G., Remy C., Barbier E.L. Evaluation of the relationship between MR estimates of blood oxygen saturation and hypoxia: impact of an anti-angiogenic treatment on a gliosarcoma model. Radiology. 2012. 265 (3): 743-752.
  5. Qiu D., Zaharchuk G., Christen T., Ni W.W., Moseley M.E. Contrast-enhanced functional blood volume imaging (CE-fBVI). NeuroImage. 2012. 62 (3): 1726-1731.
  6. Christen T., Schmiedeskamp H., Straka M., Bammer R., Zaharchuk G. Measuring brain oxygenation in humans using a multiparametric quantitative blood oxygenation level dependent MRI approach. Magnetic Resonance in Medicine. 2012. 68 (3): 905-911.
  7. Christen T., Lemasson B., Pannetier N., Farion R., Rémy C., Zaharchuk G., Barbier E.L. Is T2* enough to assess oxygenation? A Quantitative Blood-Oxygen Level Dependent analysis in brain tumor. Radiology. 2012. 262 (2): 495-502.
  8. Christen T., Zaharchuk G., Pannetier N., Serduc R., Joudiou N., Vial J.C., Remy C., Barbier E.L. Quantitative MR estimates of blood oxygenation based on T2*: a numerical study of the impact of model assumptions. Magnetic Resonance in Medicine. 2012. 67 (5): 1458-1468.
  9. Inoue M., Mlynash M., Straka M., Lansberg M.G., Zaharchuk G., Bammer R., Albers G.W. Patients With the Malignant Profile Within 3 Hours of Symptom Onset Have Very Poor Outcomes After Intravenous Tissue-Type Plasminogen Activator Therapy. STROKE.  2012; 43 (9): 2494-2496. 
  10. Andre J.B., Zaharchuk G., Fischbein N.J., Augustin M., Skare S., Straka M., Rosenberg J., Lansberg M.G., Kemp S., Wijman C.A., Albers G.W., Schwartz N.E., Bammer R. Clinical Assessment of Standard and Generalized Autocalibrating Partially Parallel Acquisition Diffusion Imaging: Effects of Reduction Factor and Spatial ResolutionAmerican Journal of Neuroradiology. 2012; 33 (7): 1337-1342. 
  11. Schmiedeskamp H., Straka M., Newbould R.D., Zaharchuk G., Andre J.B., Olivot J., Moseley M.E., Albers G.W., Bammer R. Combined spin- and gradient-echo perfusion-weighted imagingMagnetic Resonance in Medicine.  2012; 68 (1): 30-40 
  12. Qiu D., Straka M., Zun Z., Bammer R., Moseley M.E., Zaharchuk G. CBF measurements using multidelay pseudocontinuous and velocity-selective arterial spin labeling in patients with long arterial transit delays: Comparison with xenon CT CBFJournal of Magnetic Resonance Imaging. 2012; 36 (1): 110-119.
  13. Zaharchuk G. Arterial Spin Labeling for Acute Stroke: Practical ConsiderationsTranslational Stroke Research. 2012; 3 (2): 228-235. 
  14. Kleinman J.T., Zaharchuk G., Mlynash M., Ogdie A.A., Straka M., Lansberg M.G., Schwartz N.E., Kemp S., Bammer R., Albers G.W., Olivot J. Automated Perfusion Imaging for the Evaluation of Transient Ischemic Attack. STROKE.  2012; 43 (6): 1556-1560. 
  15. Zaharchuk G. Better Late than Never The Long Journey for Noncontrast Arterial Spin Labeling Perfusion Imaging in Acute Stroke. STROKE. 2012; 43 (4): 931-932.
  16. Kleinman J.T., Mlynash M., Zaharchuk G., Ogdie A.A., Straka M., Lansberg M.G., Schwartz N.E., Singh P., Kemp S., Bammer R., Albers G.W., Olivot J.M. Yield of CT perfusion for the evaluation of transient ischaemic attack. International Journal of Stroke. 2012.
  17. Zaharchuk G., Olivot J., Fischbein N.J., Bammer R., Straka M., Kleinman J.T., Albers G.W. Arterial Spin Labeling Imaging Findings in Transient Ischemic Attack Patients: Comparison with Diffusion- and Bolus Perfusion-Weighted Imaging. Cerebrovascular Diseases. 2012; 34 (3): 221-228. 
  18. Ghanouni P., Behera D., Xie J., Chen X., Moseley M., Biswal S. In vivo USPIO magnetic resonance imaging shows that minocycline mitigates macrophage recruitment to a peripheral nerve injury. Molecular Pain.  2012; 8. 
  19. Jacobs K.E., Behera D., Rosenberg J., Gold G., Moseley M., Yeomans D., Biswal S. Oral manganese as an MRI contrast agent for the detection of nociceptive activityNMR in Biomedicine. 2012; 25 (4): 563-569. 
  20. Wang C., Stebbins G.T., Medina D.A., Shah R.C., Bammer R., Moseley M.E., deToledo-Morrell L. Atrophy and dysfunction of parahippocampal white matter in mild Alzheimer's disease. Neurobiology of Aging. 2012; 33 (1): 43-52. 

Proceedings

2014

  1. Christen T., Qiu D., Ni W.W., Schmiedeskamp H., Moseley M.E., Zaharchuk G. Advanced Analysis of USPIO Injection in Normal Volunteers. ISMRM, Milan (Poster). Summa Cum Laude Award.
  2. Christen T., Jahanian H., Ni W.W., Qiu D., Moseley M.E., Zaharchuk G. Imaging the ‘Dis-Connectome’: Using Resting-State fMRI to Study Perfusion and Connectivity Deficits in Patients with Cerebrovascular Disease. ISMRM, Milan (Poster). Magna Cum Laude Award.
  3. Christen T., Jahanian H., Ni W.W., Qiu D., Moseley M.E., Zaharchuk G. Non-Contrast Mapping of Arterial Delay and Functional Connectivity Using Resting-State Functional MRI: A Study in Moyamoya Patients. ISMRM, Milan (Oral). Young Investigator Award Presentation.
  4. Lemasson B., Pannetier N., Farion R., Barbier E., Schuff N., Moseley M.E., Zaharchuk G., Christen T. Vascular Fingerprinting in Rat Brain Tumor. ISMRM, Milan (Oral).
  5. Pannetier N., Christen T., Schuff N. Effects of Realistic Vascular Networks Anisotropy on MR Microvascular Imaging. ISMRM, Milan (Oral). Magna Cum Laude Award.
  6. Soman S., Prasad G., Hitchner E., Wei Z., Moseley M.E., Rosen A. Using Structural Connectivity Graph Analysis to Predict Cognitive Decline in Patients After Carotid Endarterectomy. ISMRM, Milan (Oral). Summa Cum Laude Award
  7. Jahanian H., Christen T., Moseley M.E., Zaharchuk G. Accounting for Arterial Transit Delays Is Crucial for Identifying Functional Connectivity Networks: A Resting-State fMRI Study of the Default Mode Network in Moyamoya Disease Patients. ISMRM, Milan (Power Poster).
  8. Jahanian H., Ni W.W., Christen T., Moseley M.E., Tamura M.K., Zaharchuk G. Assessing Vascular Reactivity with Resting-State BOLD Signal Fluctuations: A Clinically Practical Alternative to the Breath-Hold Challenge. ISMRM, Milan (Poster).
  9. Ni W.W., Vriens D., de Geus-Oei L.F., Oyen W., Bengtsson T., de Crespigny A., Sanabria S. Significant impact of FDG plasma kinetics and uptake time on tumor SUV in oncology clinical trials. Proc. Soc. Nuc. Med. Mol. Im. 2014.
  10. Ni W.W., Chang C., Jahanian H., Glover G.H., Zaharchuk G. Impact of Hypertension and Aging on Restin State BOLD Response to Heart Rate Variation. ISMRM, Milan (Poster).
  11. Ni W.W., Chang C., Jahanian H., Glover G.H., Zaharchuk G. Aging-Related Reduction in Physiological Signal Contribution to Resting State fMRI. ISMRM, Milan (Poster).
  12. Holdsworth S.J., Skare S., Yeom K.W., Moseley M.E. Faster Pediatric Brain MRI. ISMRM, Milan, (Poster).
  13. Holdsworth S.J., Skare S.,Yeom K.W., Moseley M.E. Fluid attenuated inversion recovery (FLAIR) with readout-segmented (rs)-EPI. ISMRM, Milan (Oral).
  14. Park J.M., Khalighi M.M., Qiu D., Zaharchuk G., Liu C., Moseley M.E. Considerations in p-space susceptibility tensor imaging: k-space truncation effect, T2* dependence, and 3T/7T comparison. ISMRM, Milan (Poster).
  15. Zun Z., Lebel R.M., Qiu D., Shankaranarayanan A., Zaharchuk G. Comparison of CBF Augmentation with Diamox Challenge Using Arterial Spin Labeling and Xenon CT in Moyamoya Disease. ISMRM, Milan (Poster).
  16. Aksoy M., Maclaren J., Ooi M., Ehrl J., Aksoy D., Zun Z., Bammer R. Prospective Optical Motion Correction for 3D Pseudo-Continuous Arterial Spin Labelling. ISMRM, Milan (Oral).
  17. Zun Z., Lebel R.M., Qiu D., Shankaranarayanan A., Zaharchuk G. What Is the Ideal Labeling Duration for Pseudocontinuous Arterial Spin Labeling? ISMRM, Milan (Poster).
  18. Schmiedeskamp H., Peterson E., Maclaren J., O’Halloran R., Christen T., Holdsworth S., Aboussouan E., Grissom W., Bammer R. Multiband Spin- And Gradient-Echo (SAGE) fMRI.ISMRM, Milan (Poster).
  19. Lemasson B., Pannetier N., Christen T., Zaharchuk G., Schuff N., Barbier E. Mapping Blood Volume Fraction and Vessel Size Index at Steady-State: Impact of Contrast Agent Dose and Spin-Echo Time. ISMRM, Milan (Poster).
  20. Christen T., Pannetier N., Ni W.W., Qiu, D., Schuff N., Moseley M.E., Zaharchuk G. MR Vascular Fingerprinting. CBIS, Stanford (Oral).

2013

  1. Zun Z., Shankaranarayanan A., Zaharchuk G. Comparing 3D Velocity-Selective Arterial Spin Labeling to 3D Pseudocontinuous Arterial Spin Labeling. ISMRM, Salt Lake City (Poster)
  2. Zun Z., Qiu D., Rosenberg J., Zaharchuk G. Longitudinal Study of Cerebral Blood Flow Measurements in Normals Using Pseudocontinuous and Velocity-Selective Arterial Spin Labeling. ISMRM, Salt Lake City (Poster)
  3. Zun Z., Shankaranarayanan A., Zaharchuk G. Pseudocontinuous Arterial Spin Labeling with Prospective Motion Correction (PCASL-PROMO). ISMRM, Salt Lake City (Poster)
  4. Christen T., Qiu D., Ni W.W., Schmiedeskamp H., Bammer R., Moseley M.E., Zaharchuk G. Combined Spin and Gradient Echo Imaging Following Injection of USPIOs in Humans.ISMRM, Salt Lake City (Oral). Magna Cum Laude Award.
  5. Christen T., Pannetier N., Ni W.W., Qiu D., Schuff N., Moseley M.E., Zaharchuk G. A Fingerprinting Approach to Compute Blood Volume, Vessel Diameter and Blood Oxygenation Maps in the Human Brain. ISMRM, Salt Lake City (Oral). Summa Cum Laude Award.
  6. Christen T., Ni W.W., Qiu D., Moseley M.E., Zaharchuk G. Imaging the Fragile Brain: Using BOLD Signal Fluctuations to Study Perfusion in Normal Subjects and Patients with Cerebrovascular Disease. ISMRM, Salt Lake City (Poster). Magna Cum Laude Award.
  7. Ni W.W., Christen T., Zaharchuk G. Myelin Water Fraction Measurement Using Free Induction Decay and Refocused Gradient Echoes. ISMRM, Salt Lake City (ePoster).
  8. Ni W.W., Christen T., Zun Z., Zaharchuk G. Does T2' Depend on the Measurement Method? Considerations for Quantitative BOLD Oxygenation. ISMRM, Salt Lake City (ePoster).
  9. Pannetier N., Lemasson B., Christen T., Zaharchuk G., Barbier E.L., Schuff N. Quantitative BOLD Analysis Using a Numerical Model. Blood Volume, Oxygenation and Vessel Size Measurement in the Rat Brain. ISMRM, Salt Lake City (ePoster). Magna Cum Laude Award.
  10. Pannetier N., Sohlin M., Christen T., Schad L.R., Schuff N. Numerical Approach for Quantitative BOLD with Vessel Size Estimate – Validation on Phantom. ISMRM, Salt Lake City (ePoster).
  11. Qiu D., Christen T., Park J.M., Moseley M.E., Zaharchuk G. Resting State fMRI Using Multi Echo EPI (ME-EPI): A Study of Echo Time Dependence of Sensitivity. ISMRM, Salt Lake City (Poster).
  12. Qiu D., Zaharchuk G., Christen T., Ni W.W., Glover G., Moseley M.E. Resting State Neural Network Demonstrated with Cerebral Blood Volume Based fMRI Using the USPIO Agent Ferumoxytol in Humans. ISMRM, Salt Lake City (Poster). Magna Cum Laude Award.
  13. Qiu D., Zaharchuk G., Christen T., Ni W.W., Moseley M.E. Echo Time Dependence of Resting Signal Fluctuations in USPIO Based Cerebral Blood Volume Imaging: Implications for Task-Based and Resting State fMRI. ISMRM, Salt Lake City (Poster).
  14. Qiu D., Christen T., Ni W.W., Scmiedeskamp H., Zaharchuk G., Moseley M.E. Simultaneous Spin Echo and Gradient Echo for fMRI Using the USPIO Agent Ferumoxytol in Humans: Enhanced Sensitivity and Potentials for High Resolution Mapping. ISMRM, Salt Lake City (Oral).
  15. Jahanian H., Ni W.W., Christen T., Tamura M.K., Moseley M.E., Zaharchuk G. Spontaneous BOLD Signal Fluctuations in the Young and Elderly Brain: a Non-Contrast Biomarker of Cerebral Vasomotor Reactivity? ISMRM, Salt Lake City (Poster).
  16. Christen T., Zhao C., Coram M.A., Straka M., Bammer R., Albers G.W., Zaharchuk G. An ASL Collateral Score Can Identify Improved Quantitative Cerebral Blood Flow in Acute Stroke Patients. Proc AHA International Stroke Conference, Honolulu, (Poster).
  17. Andre J.B., NagpalS., Hippe D.S., Schmiedeskamp H., Bammer R., Thomas R., Straka, M., Recht L., Zaharchuk G. Cerebral Blood Flow Changes in Glioblastoma Multiforme Patients Undergoing Bevacizumab Treatment Are Seen in Both Tumor and Normal Brain. ISMRM, Salt Lake City (Poster)
  18. Holdsworth S.J., Skare S., Yeom K., Antonucci M.U., Andre J.B., Rosenberg J., Straka, M., Fischbein N.J., Zaharchuk G., Bammer R. Dual-Echo Diffusion-Weighted EPI for Better Sensitivity to Acute Stroke. ISMRM, Salt Lake City (Oral)

2012

  1. Zaharchuk G., Christen T., Qiu D., Ni W.W., Schmiedeskamp H., Bammer R., Moseley M.E. Cerebrovascular and Functional Magnetic Resonance Imaging with the Blood Pool Agent Ferumoxytol: Initial Experiences in Normal Subjects. ASNR (Oral). Outstanding Presentation Awards.
  2. Christen T., Qiu D., Ni W.W., Schmiedeskamp H., Bammer R., Moseley M.E., Zaharchuk G. Steady-State and Dynamic Susceptibility Contrast Using USPIOs in Humans. ISMRM, Melbourne (Oral). Summa Cum Laude Award.
  3. Christen T., Qiu D., Ni W.W., Hankov G., Zun Z., Moseley M.E., Zaharchuk G. High-Resolution Quantitative Cerebral Blood Volume Imaging in Humans Using the Blood Pool USPIO Contrast Agent Ferumoxytol. ISMRM, Melbourne (Poster). Magna Cum Laude Award.
  4. Christen T., Hankov G., Schmiedeskamp H., Bammer R., Zaharchuk G. Vessel Size Index and Cerebral Blood Volume Maps Using Hypercapnic Contrast at 3T. ISMRM, Melbourne (Oral).
  5. Qiu D., Zaharchuk G., Christen T., Ni W.W., Moseley M.E. Enhanced fMRI Sensitivity Using CBV Based Contrast with the Blood Pool USPIO Agent Ferumoxytol in Humans. ISMRM, Melbourne (Oral). Magna Cum Laude Award.
  6. Schmiedeskamp H., Straka M., Christen T., Andre J.B., Naqpal S., Recht L., Thomas R.P., Moseley M.E., Zaharchuk G., Bammer R. Spin- And Gradient-Echo PWI with Correction for T1- And T2(*)-Related Contrast Agent Extravasation Effects. ISMRM, Melbourne (Poster).
  7. Qiu D., Christen T., Ni W.W., Zaharchuk G., Moseley M.E. Vasculature Visualisation Using Blood Pool USPIO Contrast Agent Ferumoxytol in Humans. ISMRM, Melbourne (Poster).
  8. Schmiedeskamp H., Straka M., Christen T., Zaharchuk G., Bammer R. Precision and Accuracy of R2 and R2* Estimation with Spin- And Gradient-Echo EPI. ISMRM, Melbourne (Poster).
  9. Ni W.W., Qiu D., Christen T., Schmiedeskamp H., Bammer R., Moseley M.E., Zaharchuk G. Cerebral MR Signal Changes Induced by Ferumoxytol and Saline Dilution Boluses: Initial Human Experience. ISMRM, Melbourne (Poster).
  10. Qiu D., Christen T., Ni W.W., Zaharchuk G., Moseley M.E. Characterization of Blood Pool Half Life of USPIO Contrast Agent Ferumoxytol in Humans. ISMRM, Melbourne (Poster).
  11. Hankov G., Christen T., Schmiedeskamp H., Bammer R., Zaharchuk G. Analysis of MR Signal Dynamics During Carbogen Inhalation Using a Combined Spin- And Gradient-Echo (SAGE) EPI Sequence. ISMRM, Melbourne (e-Poster).
  12. Zun Z., Hargreaves B., Zaharchuk G. Improved Multislice Cerebral Blood Flow Imaging Using Velocity-Selective Arterial Spin Labeling. ISMRM, Melbourne (Poster)
  13. Zun Z., Hargreaves B., Zaharchuk G. Near-Contiguous Spin Echo Imaging Using Matched-Phase RF and Its Application in Velocity-Selective Arterial Spin Labeling. ISMRM, Melbourne (Poster)
  14. Qiu D., Rex D.E., Saranathan M., Lober R.M., Zaharchuk G., Moseley M.E., Yeom K.W. Functional Blood Volume Imaging (FBVI) Using Blood Pool Gadolinium Contrast Agent Gadofosveset Trisodium. ISMRM, Melbourne (Poster)

Greg Zaharchuk, MD., PhD.

Associate Professor of Radiology
Office: Lucas Center, PS-04
Phone: (650) 735-6172
Email: gregz@stanford.edu

Michael E. Moseley, PhD.

Professor, Radiology
Office: Lucas Center, Rm PS-062
Phone: (650) 723-8697
email: moseley@stanford.edu